Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Henan Taloph Pharmaceutical Stock Co.,Ltd
—
Henan Taloph Pharmaceutical Stock Co.,Ltd is led by CEO Jingliang Li, employs 2,084 people, headquartered in Zhengzhou, CN, publicly traded since 1999.
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) stock trades at $7.12 with a market capitalization of $4.41B. The stock is valued at a price-to-earnings (P/E) ratio of 78.90, price-to-book of 2.70, price-to-sales of 2.55. Over the past 52 weeks the stock has ranged between $6.24 and $9.44, and currently trades 24.6% below its 52-week high. It pays a dividend yielding 0.18%.
On profitability, Henan Taloph Pharmaceutical Stock Co.,Ltd generates a return on equity (ROE) of 3.39%, an operating margin of 3.89%, a net profit margin of 3.04%.
Official website: www.taloph.com
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) — frequently asked questions
What is Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) stock price today?
Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) is currently trading at $7.12, down 4.43% today.
What is 600222.SS P/E ratio?
Henan Taloph Pharmaceutical Stock Co.,Ltd's P/E ratio is 78.90. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 600222.SS return on equity (ROE)?
Henan Taloph Pharmaceutical Stock Co.,Ltd's return on equity (ROE) is 3.39%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Henan Taloph Pharmaceutical Stock Co.,Ltd's market cap?
Henan Taloph Pharmaceutical Stock Co.,Ltd has a market capitalization of $4.41B.
Does 600222.SS pay a dividend?
Yes. Henan Taloph Pharmaceutical Stock Co.,Ltd currently yields 0.18%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 600222.SS carry?
Henan Taloph Pharmaceutical Stock Co.,Ltd has a debt-to-equity ratio of 0.57. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 600222.SS's profit margin?
Henan Taloph Pharmaceutical Stock Co.,Ltd reports a net profit margin of 3.04% — the share of revenue left after every cost, including tax and interest.
What sector is 600222.SS in?
Henan Taloph Pharmaceutical Stock Co.,Ltd is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 600222.SS listed on?
Henan Taloph Pharmaceutical Stock Co.,Ltd trades on SHH under the ticker 600222.SS.
What is 600222.SS's 52-week range?
Over the last year Henan Taloph Pharmaceutical Stock Co.,Ltd has traded between $6.24 and $9.44.
Related — Stocks
Popular Stocks
Screens 600222.SS currently matches
On the figures above, Henan Taloph Pharmaceutical Stock Co.,Ltd passes the filters for 6 of our ready-made screens, among them Stocks Under $10, High PE Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.